Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-08 01:06 | 2022-03-01 | LLY | ELI LILLY & Co | Runge Marschall S | Director | Pharmaceutical Preparations | BUY | $246.78 | 202 | $49,850 | 15,436 | +1.3% |
| 2022-03-04 02:30 | 2022-03-01 | LLY | ELI LILLY & Co | Jonsson Patrik | Officer; SVP&Pres, LLY Imm, LLY USA&CCO | Pharmaceutical Preparations | SALE | $247.56 | 675 | $167,103 | 32,035 | -2.1% |
| 2022-03-01 00:38 | 2022-02-25 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $243.84 | 1,660 | $404,774 | 7,274 | -18.6% |
| 2022-02-18 00:40 | 2022-02-15 | LLY | ELI LILLY & Co | Yuffa Ilya | Officer; SVP & President, LLY Int'l | Pharmaceutical Preparations | SALE | $240.02 | 2,000 | $480,030 | 11,624 | -14.7% |
| 2022-01-03 18:01 | 2021-12-30 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $279.55 | 3,614 | $1,010,276 | 107,463,810 | 0.0% |
| 2021-12-28 19:25 | 2021-12-27 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $279.53 | 3,570 | $997,925 | 107,467,424 | 0.0% |
| 2021-12-18 00:19 | 2021-12-16 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $280.20 | 177,616 | $49,768,767 | 107,470,994 | -0.2% |
| 2021-12-17 00:59 | 2021-12-15 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $271.90 | 205,000 | $55,739,336 | 107,648,610 | -0.2% |
| 2021-11-05 18:19 | 2021-11-04 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $268.82 | 195,000 | $52,419,315 | 107,853,610 | -0.2% |
| 2021-10-29 21:27 | 2021-10-28 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $253.24 | 178,631 | $45,236,372 | 108,048,610 | -0.2% |
| 2021-10-28 20:13 | 2021-10-27 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $252.33 | 21,369 | $5,391,997 | 108,227,241 | 0.0% |
| 2021-08-19 18:35 | 2021-08-18 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $274.31 | 15,430 | $4,232,603 | 108,248,610 | 0.0% |
| 2021-08-18 20:20 | 2021-08-17 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $274.08 | 3,060 | $838,698 | 108,264,040 | 0.0% |
| 2021-08-10 22:48 | 2021-08-09 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $267.50 | 104,711 | $28,010,130 | 108,267,100 | -0.1% |
| 2021-08-09 19:58 | 2021-08-06 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $264.05 | 7,597 | $2,005,965 | 108,371,811 | 0.0% |
| 2021-08-05 22:52 | 2021-08-04 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $265.15 | 13,458 | $3,568,359 | 108,512,100 | 0.0% |
| 2021-08-04 22:15 | 2021-08-03 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $256.12 | 236,542 | $60,582,475 | 108,525,558 | -0.2% |
| 2021-07-22 17:47 | 2021-07-21 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $237.00 | 86,111 | $20,408,307 | 108,762,100 | -0.1% |
| 2021-07-21 18:12 | 2021-07-20 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $237.06 | 15,610 | $3,700,429 | 108,848,211 | 0.0% |
| 2021-07-15 21:03 | 2021-07-14 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $237.02 | 10,780 | $2,555,119 | 108,863,821 | 0.0% |
| 2021-07-13 22:08 | 2021-07-12 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $237.09 | 3,238 | $767,694 | 108,874,601 | 0.0% |
| 2021-07-12 19:58 | 2021-07-09 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $237.39 | 109,261 | $25,937,086 | 108,877,839 | -0.1% |
| 2021-07-07 16:17 | 2021-07-06 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $235.09 | 210,000 | $49,369,047 | 108,987,100 | -0.2% |
| 2021-07-06 20:05 | 2021-07-02 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $232.94 | 202,102 | $47,077,741 | 109,197,100 | -0.2% |
| 2021-06-25 20:16 | 2021-06-24 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $237.51 | 12,898 | $3,063,400 | 109,399,202 | 0.0% |
| 2021-06-11 17:35 | 2021-06-10 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $233.63 | 240,000 | $56,072,352 | 109,412,100 | -0.2% |
| 2021-06-10 22:35 | 2021-06-09 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $224.93 | 220,000 | $49,484,270 | 109,652,100 | -0.2% |
| 2021-06-08 22:16 | 2021-06-07 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $224.72 | 230,000 | $51,685,002 | 109,872,100 | -0.2% |
| 2021-05-25 17:39 | 2021-05-24 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $202.27 | 7,329 | $1,482,405 | 110,102,100 | 0.0% |
| 2021-05-24 18:15 | 2021-05-21 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $200.58 | 92,740 | $18,602,003 | 110,109,429 | -0.1% |
| 2021-05-21 19:57 | 2021-05-20 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $200.48 | 99,931 | $20,033,767 | 110,202,169 | -0.1% |
| 2021-05-04 02:01 | 2021-04-30 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $182.84 | 1,366 | $249,759 | 61,195 | +2.3% |
| 2021-04-30 03:31 | 2021-04-28 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $181.38 | 3,000 | $544,140 | 5,987 | -33.4% |
| 2021-03-10 22:59 | 2021-03-09 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $209.79 | 59,959 | $12,579,032 | 110,302,100 | -0.1% |
| 2021-03-09 20:26 | 2021-03-08 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $209.69 | 125,284 | $26,271,090 | 110,362,059 | -0.1% |
| 2021-01-19 21:04 | 2021-01-15 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $190.80 | 215,000 | $41,022,860 | 110,487,343 | -0.2% |
| 2021-01-14 19:23 | 2021-01-13 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $185.97 | 210,000 | $39,053,070 | 110,702,343 | -0.2% |
| 2021-01-12 19:27 | 2021-01-11 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $185.49 | 220,000 | $40,807,756 | 110,912,343 | -0.2% |
| 2020-09-10 23:25 | 2020-09-08 | LLY | ELI LILLY & Co | Barnes Melissa S | Officer; Chief Eth/Cmpl Ofcr & SVP, ERM | Pharmaceutical Preparations | SALE | $151.01 | 5,000 | $755,050 | 23,580 | -17.5% |
| 2020-08-18 22:31 | 2020-08-17 | LLY | ELI LILLY & Co | Fry Stephen F | Officer; SVP, HR & Diversity | Pharmaceutical Preparations | SALE | $150.64 | 7,204 | $1,085,211 | 100,211 | -6.7% |
| 2020-07-13 20:43 | 2020-07-09 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $170.00 | 11,000 | $1,870,000 | 18,646 | -37.1% |
| 2020-07-10 21:16 | 2020-07-09 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $169.69 | 12,961 | $2,199,392 | 111,132,343 | 0.0% |
| 2020-07-08 19:49 | 2020-07-07 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $167.29 | 210,000 | $35,131,803 | 111,145,304 | -0.2% |
| 2020-07-07 21:27 | 2020-07-06 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $166.99 | 205,000 | $34,232,089 | 111,655,304 | -0.2% |
| 2020-07-01 18:17 | 2020-06-30 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $163.20 | 166,832 | $27,227,767 | 111,560,304 | -0.1% |
| 2020-06-30 22:12 | 2020-06-29 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $163.39 | 11,431 | $1,867,760 | 111,727,136 | 0.0% |
| 2020-06-30 21:48 | 2020-06-26 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $163.01 | 31,737 | $5,173,404 | 111,738,567 | 0.0% |
| 2020-06-19 21:21 | 2020-06-18 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $161.54 | 53,770 | $8,686,043 | 111,770,304 | 0.0% |
| 2020-06-19 00:16 | 2020-06-17 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $161.38 | 161,230 | $26,019,475 | 111,824,074 | -0.1% |
| 2020-06-18 16:36 | 2020-06-16 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $162.94 | 17,000 | $2,770,000 | 29,646 | -36.4% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.